Mimedx (MDXG) Non-Current Debt (2011 - 2026)

Mimedx has disclosed Non-Current Debt across 10 years of filings, most recently posting $16.1 million for Q1 2026.

• Non-Current Debt for Q1 2026 came in at $16.1 million, down 8.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.1 million (down 8.21% YoY), and the FY2025 annual result was $16.5 million, down 7.64% from the prior year.
• Non-Current Debt came in at $16.1 million for Q1 2026 at Mimedx, down from $16.5 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $49.0 million in Q3 2023 to a low of $16.1 million in Q1 2026.
• The 5-year median for Non-Current Debt is $18.5 million (2024), against an average of $32.1 million.
• Across the five-year window, Non-Current Debt rose 1.01% in 2023 and tumbled 63.2% in 2024, its largest moves.
• Mimedx's Non-Current Debt stood at $48.6 million in 2022, then slipped by 1.02% to $48.1 million in 2023, then tumbled by 62.93% to $17.8 million in 2024, then slipped by 7.64% to $16.5 million in 2025, then decreased by 2.27% to $16.1 million in 2026.
• The last three Non-Current Debt figures came in at $16.1 million (Q1 2026), $16.5 million (Q4 2025), and $16.8 million (Q3 2025), per Business Quant data.